KR
50
10
CTAS
64
2
HSIC
44
4
SYF
83
-3
SJM
29
-2
NVDA
60
-5
KSS
43
4
EXC
47
2
RL
76
-3
BSX
70
2
VZ
25
-2
K
30
-2
CSCO
53
2
CF
38
-3
FOX
30
2
SRE
30
-2
HRL
29
2
ICE
67
3
CFG
34
4
HST
40
2
KR
50
10
CTAS
64
2
HSIC
44
4
SYF
83
-3
SJM
29
-2
NVDA
60
-5
KSS
43
4
EXC
47
2
RL
76
-3
BSX
70
2
VZ
25
-2
K
30
-2
CSCO
53
2
CF
38
-3
FOX
30
2
SRE
30
-2
HRL
29
2
ICE
67
3
CFG
34
4
HST
40
2
Financhill
Back

Krystal Biotech Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
31

KRYS
Krystal Biotech

Last Price:
174.74
Seasonality Move:
13.57%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
31
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy, Sell or Hold?

  • The current Krystal Biotech [KRYS] share price is $174.82. The Score for KRYS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KRYS Stock Price Chart

What is Krystal Biotech's stock price today?

  • The Krystal Biotech share price today is $174.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

KRYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.55 Buy
Relative Strength Index (14 RSI): 56.38 Buy
Chaikin Money Flow: 2364896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (161 - 175.66) Buy
Bollinger Bands (100): (135.05 - 180.27) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

KRYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 177.1 Sell
20-day SMA: 169 Buy
50-day SMA: 164.89 Buy
200-day SMA: 136.43 Buy
8-day EMA: 174.37 Buy
20-day EMA: 170.94 Buy
50-day EMA: 165.96 Buy
200-day EMA: 142.45 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Krystal Biotech Earnings Growth & KRYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.66 per share, an increase next quarter of $0.28 per share, an increase this year of $3.59 per share, and an increase next year of $2.08 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Krystal Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):